Asylia Diagnostics develops diagnostics technology intended to provide safer immunotherapy for cancer patients. The company focuses on diagnostic solutions to improve the safety profile of cancer immunotherapy treatments.
Andrey Khmelevskiy - CEO, Co-Founder
Anna Kostikova - Co-Founder